FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Steven Callister

Research Profile

Disorders

Lyme Disease

Living Beings

Chemicals & Drugs

Procedures

Geographic Areas

Wisconsin

Co-author Network

Publications

TOP 3
Erik Munson; Dean T Nardelli; Steven M Callister; Brian K Du Chateau; Ronald F Schell
Hamster and murine models of severe destructive Lyme arthritis.
Steven D Lovrich; Seema M Policepatil; Dean A Jobe; Todd J Kowalski; Steven M Callister
Expansion of the Midwestern focus for human granulocytic anaplasmosis into the region surrounding La Crosse, Wisconsin.
Joseph Kuo; Dean T Nardelli; Steven M Callister; Thomas F Warner; Ronald F Schell
Interleukin-35 enhances Lyme arthritis in Borrelia-vaccinated and -infected mice.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Steven Callister (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Erik Munson; Dean T Nardelli; Steven M Callister; Brian K Du Chateau; Ronald F Schell
Hamster and murine models of severe destructive Lyme arthritis.
Clinical & developmental immunology 2012;2012():504215.
2011: Steven D Lovrich; Seema M Policepatil; Dean A Jobe; Todd J Kowalski; Steven M Callister
Expansion of the Midwestern focus for human granulocytic anaplasmosis into the region surrounding La Crosse, Wisconsin.
Journal of clinical microbiology 2011;49(11):3855-9.
2011: Joseph Kuo; Dean T Nardelli; Steven M Callister; Thomas F Warner; Ronald F Schell
Interleukin-35 enhances Lyme arthritis in Borrelia-vaccinated and -infected mice.
Clinical and vaccine immunology : CVI 2011;18(7):1125-32.
2011: Dean A Jobe; Todd J Kowalski; Marissa Bloemke; Steven D Lovrich; Steven M Callister
Rapid decline of OspC borreliacidal antibodies following treatment of patients with early Lyme disease.
Clinical and vaccine immunology : CVI 2011;18(6):1034-7.
2010: William R Schwan; Adam Briska; Buffy Stahl; Trevor K Wagner; Emily Zentz; John Henkhaus; Steven D Lovrich; William A Agger; Steven M Callister; Brian DuChateau; Colin W Dykes
Use of optical mapping to sort uropathogenic Escherichia coli strains into distinct subgroups.
Microbiology (Reading, England) 2010;156(Pt 7):2124-35.
2010: Rhonda L LaFleur; Steven M Callister; Jennifer C Dant; Dean A Jobe; Steven D Lovrich; Thomas F Warner; Terri L Wasmoen; Ronald F Schell
One-year duration of immunity induced by vaccination with a canine Lyme disease bacterin.
Clinical and vaccine immunology : CVI 2010;17(5):870-4.
2009: Dean T Nardelli; Erik L Munson; Steven M Callister; Ronald F Schell
Human Lyme disease vaccines: past and future concerns.
Future microbiology 2009;4(4):457-69.
2008: Nicholas J Kotloski; Dean T Nardelli; Sara Heil Peterson; Jose R Torrealba; Thomas F Warner; Steven M Callister; Ronald F Schell
Interleukin-23 is required for development of arthritis in mice vaccinated and challenged with Borrelia species.
Clinical and vaccine immunology : CVI 2008;15(8):1199-207.
2008: Dean T Nardelli; Kee Hang Kevin Luk; Nicholas J Kotloski; Thomas F Warner; Jose R Torrealba; Steven M Callister; Ronald F Schell
Role of IL-17, transforming growth factor-beta, and IL-6 in the development of arthritis and production of anti-outer surface protein A borreliacidal antibodies in Borrelia-vaccinated and -challenged mice.
FEMS immunology and medical microbiology 2008;53(2):265-74.
2008: Dean A Jobe; Steven D Lovrich; Krista E Asp; Michelle Mathiason; Stephanie E Albrecht; Ronald F Schell; Steven M Callister
Significantly improved accuracy of diagnosis of early Lyme disease by peptide enzyme-linked immunosorbent assay based on the borreliacidal antibody epitope of Borrelia burgdorferi OspC.
Clinical and vaccine immunology : CVI 2008;15(6):981-5.
2008: Dean T Nardelli; Steven M Callister; Ronald F Schell
Lyme arthritis: current concepts and a change in paradigm.
Clinical and vaccine immunology : CVI 2008;15(1):21-34.
2007: Sara Heil Peterson; Dean T Nardelli; Thomas F Warner; Steven M Callister; Jose Torrealba; Ronald F Schell
Anti-p19 antibody treatment exacerbates lyme arthritis and enhances borreliacidal activity.
Clinical and vaccine immunology : CVI 2007;14(5):510-7.
2007: Steven D Lovrich; Rhonda L La Fleur; Dean A Jobe; Jennifer C Johnson; Krista E Asp; Ronald F Schell; Steven M Callister
Borreliacidal OspC antibody response of canines with Lyme disease differs significantly from that of humans with Lyme disease.
Clinical and vaccine immunology : CVI 2007;14(5):635-7.
2006: Beth A Fredricks; David J DeCoster; Youngmi Kim; Nancy Sparks; Steven M Callister; Ronald F Schell
Rapid pyrazinamide susceptibility testing of Mycobacterium tuberculosis by flow cytometry.
Journal of microbiological methods 2006;67(2):266-72.
2006: Dean T Nardelli; Thomas F Warner; Steven M Callister; Ronald F Schell
Anti-CD25 antibody treatment of mice vaccinated and challenged with Borrelia spp. does not exacerbate arthritis but inhibits borreliacidal antibody production.
Clinical and vaccine immunology : CVI 2006;13(8):884-91.
2006: Corey A Amlong; Dean T Nardelli; Sara Heil Peterson; Thomas F Warner; Steven M Callister; Ronald F Schell
Anti-interleukin-15 prevents arthritis in Borrelia-vaccinated and -infected mice.
Clinical and vaccine immunology : CVI 2006;13(2):289-96.
2006: Erik L Munson; Dean T Nardelli; K H Kevin Luk; Monica C Remington; Steven M Callister; Ronald F Schell
Interleukin-6 promotes anti-OspA borreliacidal antibody production in vitro.
Clinical and vaccine immunology : CVI 2006;13(1):19-25.
2005: Dean T Nardelli; Joseph P Cloute; K H Kevin Luk; Jose Torrealba; Thomas F Warner; Steven M Callister; Ronald F Schell
CD4(+) CD25(+) T cells prevent arthritis associated with Borrelia vaccination and infection.
Clinical and diagnostic laboratory immunology 2005;12(6):786-92.
2005: Steven D Lovrich; Dean A Jobe; Ronald F Schell; Steven M Callister
Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.
Clinical and diagnostic laboratory immunology 2005;12(6):746-51.
2005: David J DeCoster; R M Vena; Steven M Callister; Ronald F Schell
Susceptibility testing of Mycobacterium tuberculosis: comparison of the BACTEC TB-460 method and flow cytometric assay with the proportion method.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2005;11(5):372-8.
2005: ronald go; Steven D Lovrich; Steven M Callister; Lori A Meyer; Wayne A Bottner; John P Farnen
Human cyclic thrombocytopenia and Anaplasma spp. infection.
European journal of haematology 2005;74(2):182-3.
2004: Dean T Nardelli; Matthew Burchill; Douglas M England; Jose Torrealba; Steven M Callister; Ronald F Schell
Association of CD4+ CD25+ T cells with prevention of severe destructive arthritis in Borrelia burgdorferi-vaccinated and challenged gamma interferon-deficient mice treated with anti-interleukin-17 antibody.
Clinical and diagnostic laboratory immunology 2004;11(6):1075-84.
2004: Michael J Schlicht; Steven D Lovrich; Jeffrey S Sartin; Patricia Karpinsky; Steven M Callister; William A Agger
High prevalence of genital mycoplasmas among sexually active young adults with urethritis or cervicitis symptoms in La Crosse, Wisconsin.
Journal of clinical microbiology 2004;42(10):4636-40.
2004: Ronald F Schell; Dean T Nardelli; David J DeCoster; SM Kirk; Steven M Callister
Mycobacterium tuberculosis susceptibility testing by flow cytometry.
Current protocols in cytometry / editorial board, J. Paul Robinson, managing editor ... [et al.] 2004;Chapter 11():Unit 11.7.
2004: Erik L Munson; David J DeCoster; Dean T Nardelli; Douglas M England; Steven M Callister; Ronald F Schell
Neutralization of gamma interferon augments borreliacidal antibody production and severe destructive Lyme arthritis in C3H/HeJ mice.
Clinical and diagnostic laboratory immunology 2004;11(1):35-41.
2003: Dean A Jobe; Steven D Lovrich; Ronald F Schell; Steven M Callister
C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme disease.
Clinical and diagnostic laboratory immunology 2003;10(4):573-8.
2003: Matthew Burchill; Dean T Nardelli; Douglas M England; David J DeCoster; John A Christopherson; Steven M Callister; Ronald F Schell
Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi.
Infection and immunity 2003;71(6):3437-42.
2003: John A Christopherson; Erik L Munson; Douglas M England; Cindy L Croke; Monica C Remington; Melanie L Molitor; David J DeCoster; Steven M Callister; Ronald F Schell
Destructive arthritis in vaccinated interferon gamma-deficient mice challenged with Borrelia burgdorferi: modulation by tumor necrosis factor alpha.
Clinical and diagnostic laboratory immunology 2003;10(1):44-52.
2002: Erik L Munson; Brian K Du Chateau; Jani R Jensen; Steven M Callister; David J DeCoster; Ronald F Schell
Gamma interferon inhibits production of Anti-OspA borreliacidal antibody in vitro.
Clinical and diagnostic laboratory immunology 2002;9(5):1095-101.
2002: Steven M Callister; Dean A Jobe; William A Agger; Ronald F Schell; Todd J Kowalski; Steven D Lovrich; Jennifer A Marks
Ability of the borreliacidal antibody test to confirm lyme disease in clinical practice.
Clinical and diagnostic laboratory immunology 2002;9(4):908-12.
2002: Craig Jackson; Steven D Lovrich; William A Agger; Steven M Callister
Reassessment of a midwestern Lyme disease focus for Borrelia burgdorferi and the human granulocytic ehrlichiosis agent.
Journal of clinical microbiology 2002;40(6):2070-3.
2001: Monica C Remington; Erik L Munson; Steven M Callister; M L Molitor; John A Christopherson; David J DeCoster; Steven D Lovrich; Ronald F Schell
Interleukin-6 enhances production of anti-OspC immunoglobulin G2b borreliacidal antibody.
Infection and immunity 2001;69(7):4268-75.
2000: Steven M Callister; Dean A Jobe; Ronald F Schell; Steven D Lovrich; K L Onheiber; J B Korshus
Detection of borreliacidal antibodies in dogs after challenge with Borrelia burgdorferi-infected ixodes scapularis ticks.
Journal of clinical microbiology 2000;38(10):3670-4.
2000: Erik L Munson; Brian K Du Chateau; Dean A Jobe; Steven D Lovrich; Steven M Callister; Ronald F Schell
Production of borreliacidal antibody to outer surface protein A in vitro and modulation by interleukin-4.
Infection and immunity 2000;68(10):5496-501.
2000: R M Vena; Erik L Munson; David J DeCoster; Cindy L Croke; D B Fett; Steven M Callister; Ronald F Schell
Flow cytometric testing of susceptibilities of Mycobacterium avium to amikacin, ciprofloxacin, clarithromycin and rifabutin in 24 hours.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2000;6(7):368-75.
2000: Cindy L Croke; Erik L Munson; Steven D Lovrich; John A Christopherson; Monica C Remington; Douglas M England; Steven M Callister; Ronald F Schell
Occurrence of severe destructive lyme arthritis in hamsters vaccinated with outer surface protein A and challenged with Borrelia burgdorferi.
Infection and immunity 2000;68(2):658-63.
2000: C A Wieneke; Steven D Lovrich; Steven M Callister; Dean A Jobe; Jennifer A Marks; Ronald F Schell
Evaluation of whole-cell and OspC enzyme-linked immunosorbent assays for discrimination of early lyme borreliosis from OspA vaccination.
Journal of clinical microbiology 2000;38(1):313-7.
1999: Dean A Jobe; N Rawal; Ronald F Schell; Steven M Callister
Detection of borreliacidal antibodies in Lyme borreliosis patient sera containing antimicrobial agents.
Clinical and diagnostic laboratory immunology 1999;6(6):930-3.
1999: A V Moore; SM Kirk; Steven M Callister; G H Mazurek; Ronald F Schell
Safe determination of susceptibility of Mycobacterium tuberculosis to antimycobacterial agents by flow cytometry.
Journal of clinical microbiology 1999;37(3):479-83.
1999: B K DuChateau; Erik L Munson; Douglas M England; Steven D Lovrich; Steven M Callister; Jani R Jensen; Ronald F Schell
Macrophages interact with enriched populations of distinct T lymphocyte subsets for the induction of severe destructive Lyme arthritis.
Journal of leukocyte biology 1999;65(2):162-70.
1998: J C Rousselle; Steven M Callister; Ronald F Schell; Steven D Lovrich; Dean A Jobe; Jennifer A Marks; C A Wieneke
Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi.
The Journal of infectious diseases 1998;178(3):733-41.
1998: SM Kirk; Ronald F Schell; A V Moore; Steven M Callister; G H Mazurek
Flow cytometric testing of susceptibilities of Mycobacterium tuberculosis isolates to ethambutol, isoniazid, and rifampin in 24 hours.
Journal of clinical microbiology 1998;36(6):1568-73.
1998: Jani R Jensen; Brian K Du Chateau; Erik L Munson; Steven M Callister; Ronald F Schell
Inhibition of the production of anti-OspA borreliacidal antibody with T cells from hamsters vaccinated against Borrelia burgdorferi.
Infection and immunity 1998;66(4):1507-12.
1997: Steven M Callister; Ronald F Schell; Steven D Lovrich
Enhanced sensitivity of the borreliacidal-antibody test.
Mayo Clinic proceedings. Mayo Clinic 1997;72(11):1093-4.
1997: B K DuChateau; Jani R Jensen; Douglas M England; Steven M Callister; Steven D Lovrich; Ronald F Schell
Macrophages and enriched populations of T lymphocytes interact synergistically for the induction of severe, destructive Lyme arthritis.
Infection and immunity 1997;65(7):2829-36.
1997: L L Bakken; Steven M Callister; P J Wand; Ronald F Schell
Interlaboratory comparison of test results for detection of Lyme disease by 516 participants in the Wisconsin State Laboratory of Hygiene/College of American Pathologists Proficiency Testing Program.
Journal of clinical microbiology 1997;35(3):537-43.
1997: SM Kirk; Steven M Callister; L C Lim; Ronald F Schell
Rapid susceptibility testing of Candida albicans by flow cytometry.
Journal of clinical microbiology 1997;35(2):358-63.
1996: M L Padilla; Steven M Callister; Ronald F Schell; G L Bryant; Dean A Jobe; Steven D Lovrich; B K DuChateau; Jani R Jensen
Characterization of the protective borreliacidal antibody response in humans and hamsters after vaccination with a Borrelia burgdorferi outer surface protein A vaccine.
The Journal of infectious diseases 1996;174(4):739-46.
1996: Steven M Callister; Dean A Jobe; Ronald F Schell; C S Pavia; Steven D Lovrich
Sensitivity and specificity of the borreliacidal-antibody test during early Lyme disease: a "gold standard"?
Clinical and diagnostic laboratory immunology 1996;3(4):399-402.
1996: B K Du Chateau; Douglas M England; Steven M Callister; L C Lim; Steven D Lovrich; Ronald F Schell
Macrophages exposed to Borrelia burgdorferi induce Lyme arthritis in hamsters.
Infection and immunity 1996;64(7):2540-7.
1996: J R Creson; L C Lim; N J Glowacki; Steven M Callister; Ronald F Schell
Detection of anti-Borrelia burgdorferi antibody responses with the borreliacidal antibody test, indirect fluorescent-antibody assay performed by flow cytometry, and western immunoblotting.
Clinical and diagnostic laboratory immunology 1996;3(2):184-90.
1995: Steven D Lovrich; Steven M Callister; B K DuChateau; L C Lim; J Winfrey; S P Day; Ronald F Schell
Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection.
Infection and immunity 1995;63(6):2113-9.
1995: M A Norden; T A Kurzynski; S E Bownds; Steven M Callister; Ronald F Schell
Rapid susceptibility testing of Mycobacterium tuberculosis (H37Ra) by flow cytometry.
Journal of clinical microbiology 1995;33(5):1231-7.
1994: Steven M Callister; Ronald F Schell; L C Lim; Dean A Jobe; K L Case; G L Bryant; P E Molling
Detection of borreliacidal antibodies by flow cytometry. An accurate, highly specific serodiagnostic test for Lyme disease.
Archives of internal medicine 1994;154(14):1625-32.
1994: Steven D Lovrich; Steven M Callister; L C Lim; B K DuChateau; Ronald F Schell
Seroprotective groups of Lyme borreliosis spirochetes from North America and Europe.
The Journal of infectious diseases 1994;170(1):115-21.
1994: L C Lim; Douglas M England; B K DuChateau; N J Glowacki; J R Creson; Steven D Lovrich; Steven M Callister; Dean A Jobe; Ronald F Schell
Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi.
Infection and immunity 1994;62(7):2825-33.
1994: Dean A Jobe; Steven M Callister; L C Lim; Steven D Lovrich; Ronald F Schell
Ability of canine Lyme disease vaccine to protect hamsters against infection with several isolates of Borrelia burgdorferi.
Journal of clinical microbiology 1994;32(3):618-22.
1994: Y F Liu; L C Lim; K Schell; Steven D Lovrich; Steven M Callister; Ronald F Schell
Differentiation of borreliacidal activity caused by immune serum or antimicrobial agents by flow cytometry.
Clinical and diagnostic laboratory immunology 1994;1(2):145-9.
1994: Steven M Callister; Ronald F Schell; Steven D Lovrich; Dean A Jobe
Lyme disease: laboratory diagnosis and serologic testing.
Endeavour 1994;18(2):80-4.
1994: L C Lim; Y F Liu; K Schell; Steven D Lovrich; Steven M Callister; Ronald F Schell
Detection of borreliacidal antibody by using acridine orange and flow cytometry.
Clinical and diagnostic laboratory immunology 1994;1(1):44-50.
1993: Steven D Lovrich; Steven M Callister; L C Lim; Ronald F Schell
Seroprotective groups among isolates of Borrelia burgdorferi.
Infection and immunity 1993;61(10):4367-74.
1993: Dean A Jobe; Steven M Callister; Ronald F Schell
Recovery of Borrelia burgdorferi by filtration.
Journal of clinical microbiology 1993;31(7):1896-8.
1993: Steven M Callister; Ronald F Schell; K L Case; Steven D Lovrich; S P Day
Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test.
The Journal of infectious diseases 1993;167(1):158-64.
1992: L L Bakken; K L Case; Steven M Callister; N J Bourdeau; Ronald F Schell
Performance of 45 laboratories participating in a proficiency testing program for Lyme disease serology.
JAMA : the journal of the American Medical Association 1992;268(7):891-5.
1992: W A Agger; Steven M Callister; Dean A Jobe
In vitro susceptibilities of Borrelia burgdorferi to five oral cephalosporins and ceftriaxone.
Antimicrobial agents and chemotherapy 1992;36(8):1788-90.
1992: John L Schmitz; Ronald F Schell; Steven M Callister; Steven D Lovrich; S P Day; J E Coe
Immunoglobulin G2 confers protection against Borrelia burgdorferi infection in LSH hamsters.
Infection and immunity 1992;60(7):2677-82.
1992: K F Sachsenmeier; K Schell; L W Morrissey; D R Pennell; R M West; Steven M Callister; Ronald F Schell
Detection of borreliacidal antibodies in hamsters by using flow cytometry.
Journal of clinical microbiology 1992;30(6):1457-61.
1991: John L Schmitz; Steven D Lovrich; Steven M Callister; Ronald F Schell
Depletion of complement and effects on passive transfer of resistance to infection with Borrelia burgdorferi.
Infection and immunity 1991;59(10):3815-8.
1991: Steven M Callister; Ronald F Schell; Steven D Lovrich
Lyme disease assay which detects killed Borrelia burgdorferi.
Journal of clinical microbiology 1991;29(9):1773-6.
1991: Steven D Lovrich; Steven M Callister; John L Schmitz; J D Alder; Ronald F Schell
Borreliacidal activity of sera from hamsters infected with the Lyme disease spirochete.
Infection and immunity 1991;59(8):2522-8.
1991: John L Schmitz; Ronald F Schell; Steven D Lovrich; Steven M Callister; J E Coe
Characterization of the protective antibody response to Borrelia burgdorferi in experimentally infected LSH hamsters.
Infection and immunity 1991;59(6):1916-21.
1991: W Agger; K L Case; G L Bryant; Steven M Callister
Lyme disease: clinical features, classification, and epidemiology in the upper midwest.
Medicine 1991;70(2):83-90.
1991: Steven M Callister; J A Nelson; Ronald F Schell; Dean A Jobe; R Bautz; W A Agger; J Coggins
Survey for Ixodes spp. and Borrelia burgdorferi in southeastern Wisconsin and northeastern Illinois.
Journal of clinical microbiology 1991;29(2):403-6.
1990: Steven M Callister; K L Case; W A Agger; Ronald F Schell; R C Johnson; J L Ellingson
Effects of bovine serum albumin on the ability of Barbour-Stoenner-Kelly medium to detect Borrelia burgdorferi.
Journal of clinical microbiology 1990;28(2):363-5.
1989: A Hejka; John L Schmitz; Douglas M England; Steven M Callister; Ronald F Schell
Histopathology of Lyme arthritis in LSH hamsters.
The American journal of pathology 1989;134(5):1113-23.
1989: Steven M Callister; W A Agger; Ronald F Schell; K M Brand
Efficacy of the urinary bladder for isolation of Borrelia burgdorferi from naturally infected, wild Peromyscus leucopus.
Journal of clinical microbiology 1989;27(4):773-4.
1988: Steven M Callister; W A Agger; Ronald F Schell; J L Ellingson
Borrelia burgdorferi infection surrounding La Crosse, Wis.
Journal of clinical microbiology 1988;26(12):2632-6.
1987: W A Agger; Steven M Callister
Intestinal infections with Aeromonas.
Annals of internal medicine 1987;106(3):479.
1987: Steven M Callister; W A Agger
Enumeration and characterization of Aeromonas hydrophila and Aeromonas caviae isolated from grocery store produce.
Applied and environmental microbiology 1987;53(2):249-53.
1986: W A Agger; T H Cogbill; H Busch; J Landercasper; Steven M Callister
Wounds caused by corn-harvesting machines: an unusual source of infection due to gram-negative bacilli.
Reviews of infectious diseases 1986;8(6):927-31.